Teladoc Health, Inc. (NYSE:TDOC) Insider Sells $16,175.88 in Stock

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) insider Fernando M. Rodrigues sold 2,358 shares of the stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $16,175.88. Following the completion of the transaction, the insider now owns 4,174 shares in the company, valued at approximately $28,633.64. The trade was a 36.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

Fernando M. Rodrigues also recently made the following trade(s):

• On Tuesday, June 3rd, Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock. The shares were sold at an average price of $6.91, for a total value of $28,842.34.

Teladoc Health Price Performance

TDOC stock traded down $0.20 during trading on Thursday, reaching $6.93. The company's stock had a trading volume of 5,451,781 shares, compared to its average volume of 6,260,843. Teladoc Health, Inc. has a 1 year low of $6.35 and a 1 year high of $15.21. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $1.21 billion, a P/E ratio of -1.20 and a beta of 1.82. The company's fifty day moving average is $7.18 and its 200-day moving average is $9.16.

Wall Street Analyst Weigh In

TDOC has been the topic of a number of recent analyst reports. Piper Sandler dropped their price target on Teladoc Health from $13.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, February 27th. Wells Fargo & Company dropped their price target on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a report on Thursday, May 8th. Jefferies Financial Group dropped their price target on Teladoc Health from $10.00 to $8.00 and set a "hold" rating on the stock in a report on Monday, April 21st. Stifel Nicolaus dropped their price target on Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, May 1st. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $9.60.

Institutional Investors Weigh In On Teladoc Health

A number of institutional investors have recently bought and sold shares of TDOC. Point72 Asset Management L.P. increased its stake in Teladoc Health by 33.6% in the 4th quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock worth $101,625,000 after buying an additional 2,813,568 shares in the last quarter. Maple Rock Capital Partners Inc. increased its stake in Teladoc Health by 189.5% in the 4th quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock worth $32,369,000 after buying an additional 2,331,000 shares in the last quarter. Two Sigma Investments LP purchased a new stake in Teladoc Health in the 4th quarter worth $18,348,000. Two Sigma Advisers LP increased its stake in Teladoc Health by 213.0% in the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock worth $20,532,000 after buying an additional 1,537,094 shares in the last quarter. Finally, Nuveen LLC purchased a new position in shares of Teladoc Health during the first quarter valued at about $11,789,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.